SOPHION BIOSCIENCE A/S: Financial statements 2021
CVR: 10021065
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
SOPHION BIOSCIENCE A/S (CVR 10021065) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 98,346,000 and a net result of DKK 36,324,000 compared with DKK 25,217,000 the year before. That is an increase of 26.9% compared with the year before. Equity in the 2021 report amounted to DKK 143,846,000. The solvency ratio was 82.3%. The company had 41 employees in the financial year.
- Gross Profit
- DKK 98,346,000
- Profit/Loss
- DKK 36,324,000
- Equity
- DKK 143,846,000
- Total Assets
- DKK 174,724,000
- Employees
- 41
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 98.3 mio. | 36.3 mio. | 143.8 mio. | 41 |
| 2020 | - | 77.5 mio. | 25.2 mio. | 106.5 mio. | 35 |
| 2019 | - | 78.4 mio. | 22.6 mio. | 101.1 mio. | 38 |
| 2018 | - | 70.8 mio. | 40.3 mio. | 98.3 mio. | 38 |
| 2017 | - | 62.1 mio. | 17.3 mio. | 101.3 mio. | 41 |
Official annual report
Find more companies like SOPHION BIOSCIENCE A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
SOPHION BIOSCIENCE A/S has published its annual report for 2020. Gross profit came to DKK 77,484,000, and the net result was DKK 25,217,000.
As of February 8, 2021, Harald Høegh has joined the board of directors of SOPHION BIOSCIENCE A/S.
As of February 8, 2021, Eirik Lauglo has joined the board of directors of SOPHION BIOSCIENCE A/S.
About SOPHION BIOSCIENCE A/S
SOPHION BIOSCIENCE A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named IONS A/S and KR 228 A/S. The management consists of Michel Krall Jürgens. The board consists of Harald Høegh (chair), Eirik Lauglo, Gustaf Peter Reinhold von Ehrenheim and Peter Max. The company is owned by Sapphire Bioscience Holding ApS. The company has 86 employees (2026). In 2025, the company reported a gross profit of DKK 102,112,000 and a net result of DKK 4,354,000 compared with DKK 39,127,000 the year before. Equity in the 2025 report amounted to DKK 178,418,000.